In the paper of Laden et al. [31], the presence was observed of a small percentage of ALDH1A1+ cells in A2780 CIS-resistant cell line and about 50% in SKOV-3 PAC-resistant cell line. The gene discussed is ALDH1A1; the disease is in situ carcinoma.